You are here

Knowledge Science

Primary tabs

The Knowledge Science working group is focused on exploring the advancement of knowledge science.

The mission of the Knowledge Science working group is to explore the advancement of knowledge science.

Members

Joyce Fedeczko Kathy Gilbeaux Maeryn Obley mdmcdonald mike kraft Siftar
tkm tom.mcginn

Email address for group

knowledge-science@m.resiliencesystem.org

COVID "Long haulers" --more background on their problems

How many people get ‘long COVID’ – and who is most at risk?

A few months ago, a young athletic guy came into my clinic where I’m an infectious disease physician and COVID-19 immunology researcher. He felt tired all the time, and, importantly to him, was having difficulty mountain biking. Three months earlier, he had tested positive for COVID-19. He is the kind of person you might expect to have a few days of mild symptoms before recovering fully. But when he walked into my clinic, he was still experiencing symptoms of COVID-19 and he could not mountain bike at the level he was able to before.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

People With Dementia Are Twice as Likely to Get Covid--Study

People with dementia had significantly greater risk of contracting the coronavirus, and they were much more likely to be hospitalized and die from it, than people without dementia, a new study of millions of medical records in the United States has found.

Their risk could not be entirely explained by characteristics common to people with dementia that are known risk factors for Covid-19: old age, living in a nursing home and having conditions like obesity, asthma, diabetes and cardiovascular disease. After researchers adjusted for those factors, Americans with dementia were still twice as likely to have gotten Covid-19 as of late last summer.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

ANALYSIS: How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead

Nearly a year into the coronavirus pandemic, as thousands of patients are dying every day in the United States and widespread vaccination is still months away, doctors have precious few drugs to fight the virus.

A handful of therapies — remdesivir, monoclonal antibodies and the steroid dexamethasone — have improved the care of Covid patients, putting doctors in a better position than they were when the virus surged last spring. But these drugs are not cure-alls and they’re not for everyone, and efforts to repurpose other drugs, or discover new ones, have not had much success.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Antibody Drugs Could Act as a Temporary Covid-19 Vaccine

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 0.748 seconds.